Skip to main content

Want a detailed portfolio tracker?

Pluri (PLUR) P/E (2011 - 2026)

Pluri (PLUR) P/E from Jun 30, 2011 to Jun 3, 2026. The TTM Pluri (PLUR) P/E is -0.82. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pluri (PLUR)

YearP/EChange
2026-0.82-13.94%
2025-0.96-17.87%
2024-1.16+35.43%
2023-0.86+8.67%
2022-0.79-11.64%
2021-0.90-80.51%
2020-4.59+155.70%
2019-1.80-44.40%
2018-3.23-27.26%
2017-4.44-13.20%
2016-5.12+32.64%
2015-3.86-38.17%
2014-6.24-28.96%
2013-8.78+5.89%
2012-8.30-36.00%
2011-12.96N/A

Comparison Pluri (PLUR) P/E with competitors

Pluri (PLUR) P/E is -0.82.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.21%
NBYStablecoin Development Corp0.10-112.42%
ENLVEnlivex Therapeutics Ltd0.15-118.25%
FGENFibroGen Inc0.24-129.16%
TRAWTraws Pharma Inc0.47-157.44%
FBIOFortress Biotech Inc0.71-185.77%
CHRSCoherus Biosciences Inc0.98-218.82%
ORMPOramed Pharmaceuticals Inc1.47-278.99%
AGENAgenus Inc2.05-348.85%
VIVSVivoSim Labs Inc2.54-408.04%
INVAInnoviva Inc3.19-487.34%
CRMDCorMedix Inc3.65-542.88%
ABEOAbeona Therapeutics Inc4.20-610.82%
VXRTVaxart Inc4.26-617.70%
CVACCureVac N.V.4.45-640.05%
SRPTSarepta Therapeutics Inc4.62-661.75%
GLPGGalapagos NV4.86-690.25%
RIGLRigel Pharmaceuticals4.92-697.62%
ZVRAZevra Therapeutics Inc4.97-704.24%
ABUSArbutus Biopharma Corp5.69-791.67%
CGENCompugen Ltd7.38-997.01%
AUPHAurinia Pharmaceuticals Inc9.25-1223.87%
ACADAcadia Pharmaceuticals Inc9.59-1264.77%
OMEROmeros Corporation9.88-1300.65%
SPROSpero Therapeutics Inc10.73-1404.07%
ADMAAdma Biologics Inc11.33-1476.46%
SVASinovac Biotech Ltd11.44-1489.27%
TBPHTheravance Biopharma Inc11.78-1530.64%
HRMYHarmony Biosciences Holdings Inc12.18-1579.70%
TGTXTG Therapeutics Inc13.18-1701.06%
INCYIncyte Corp13.38-1725.67%
SABSSAB Biotherapeutics Inc14.06-1807.76%
XOMAXOMA Corp14.95-1915.57%
REGNRegeneron Pharmaceuticals Inc14.98-1919.83%
PBYIPuma Biotechnology Inc15.05-1928.35%
EXELExelixis Inc15.79-2018.79%
NAGENiagen Bioscience Inc16.35-2086.83%
CPRXCatalyst Pharmaceuticals Inc17.34-2207.07%
MDXGMimedx Group Inc17.38-2210.79%
ARGXArgen X SE23.07-2902.78%
HALOHalozyme Therapeutics Inc23.20-2918.45%
XOMAOXOMA Corp25.34-3178.94%
VRTXVertex Pharmaceuticals Inc25.66-3216.72%
XOMAPXOMA Corp25.67-3218.45%
CTMXCytomX Therapeutics Inc25.70-3221.83%
ASNDAscendis Pharma A/S26.35-3301.55%
RPRXRoyalty Pharma plc - Class A27.50-3440.20%
SLNOSoleno Therapeutics Inc29.02-3624.84%
LGNDLigand Pharmaceuticals Inc - Class B30.19-3767.12%
BMRNBiomarin Pharmaceutical Inc37.51-4656.46%
APLSApellis Pharmaceuticals Inc39.02-4840.37%
KRYSKrystal Biotech Inc39.70-4922.54%
GMABGenmab40.20-4984.01%
ONCBeiGene Ltd67.03-8242.57%
TECHBio-Techne Corp68.59-8433.07%
VCELVericel Corp80.63-9895.01%
PHARPharming Group N.V.87.74-10758.86%
ALNYAlnylam Pharmaceuticals Inc124.93-15277.21%
TLXTelix Pharmaceuticals Ltd139.89-17094.22%
CORTCorcept Therapeutics Inc158.39-19341.47%